<DOC>
	<DOC>NCT00631943</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of Lyrica in Indian patients with nerve pain</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Inclusion criteria: Peripheral neuropathic pain Score of at least 40 mm on the VAS of the SFMPQ at screening and baseline Completion of at least 4 daily pain diary entries with an average daily pain score of at least 4 over the 7 days prior to baseline Exclusion criteria: (none)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>